The medical cannabis industry in Latin America.
Seven countries, seven distinct regulatory frameworks. Latin America today concentrates some of the most advanced medical cannabis regulations in the world —Uruguay as a global pioneer since 2013, Colombia as a consolidated exporter, Argentina with its network of patients registered in REPROCANN, Brazil consolidating a new regulatory framework in 2026— alongside systems still under construction such as Paraguay and Mexico. Operating in this ecosystem requires clarity on which regulatory track applies to each operation, and CannaTech provides that clarity.
Seven countries, one coherent reading.
Are you evaluating an operation in one or several of these markets? CannaTech advises on the applicable regulatory framework, designs the operational structure and develops the technology that sustains it.